Dr. Anne Bang leads efforts at the Conrad Prebys Center for Chemical Genomics to develop patient cell specific and human induced pluripotent stem cell (hiPSC)-based disease models for drug screening and drug target identification. Her research program is primarily focused on neurological and neuromuscular disease, with the aim of designing human cell-based models and assays that reflect higher order cellular functions and recapitulate disease phenotypes, yet have the throughput and reproducibility required for drug discovery.
The successful candidate will be primarily responsible for conducting research related to developing patient specific, cell based, “disease in a dish” models for neurological disease to screen for drugs, validate new targets and chemical molecules, and probe underlying cellular and molecular processes. The project will focus on the development of models representing neurological disease phenotypes, using patient specific induced pluripotent stem cells (iPSC), and will utilize high throughput drug screening technologies.
Employer: Sanford Burnham Prebys Medical Discovery Institute
Location: La Jolla, CA
Degree required: MD or PhD
Job posted: November 19th, 2018